News

ImmuPharma’s clinical trial began last summer and up to now two lower dose levels have been tested. The initial dose level of 1 mg/kg did not show any

The study is designed to provide additional data, if required, by the US Food and Drug Administration (FDA) for the approval of RHUCIN at the 50 U/kg dose.

The study results showed that TMC435 was safe and well-tolerated with no clinically relevant differences in adverse events between treatment groups and standard of care. In the treatment

FT1050 is a small, SCM-designed molecule which enhances hematopoietic stem cell support during the normal course of a stem cell transplant in patients suffering from hematologic malignancies, such

Datong’s products will equip Elsevier to foray into the emerging clinical decision support (CDS) market in China, thereby helping Chinese hospitals to improve their quality of care through

Acadra is an investigational, intravenous, small molecule that is transformed to its monophosphate active form (ZMP) once present within cells. It selectively induces apoptosis to B-cell leukemic cells

Reportedly, Wockhardt was the first in Asia and only the fourth company in the world to have developed, manufactured and marketed Wosulin, recombinant insulin injectables. As a result

The first global, phase 3, double-blind, randomized study, known as TMC435-C208 or QUEST-1 (QD dosing of TMC435 of previously untreated Genotype 1 patienTs-1), will evaluate a single TMC435

Through the proposal, BARDA seeks to procure 1.7 million courses of a smallpox antiviral. The proposal states that the contract would contain an option to obtain up to